DOCSLIB.ORG

Supplementary Table 3. Alternative Exon Usage Following PRMT6 Knockdown in MCF-7 Cells. Table Shows Gene Symbol, NCBI Link

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Table 3. Alternative Exon Usage Following PRMT6 Knockdown in MCF-7 Cells. Table Shows Gene Symbol, NCBI Link Supplementary Table 3. Alternative exon usage following PRMT6 knockdown in MCF-7 cells. Table shows gene symbol, NCBI link, gene annotation, significant alternative exon usage and alternative exon usage corrected with Benjamini and Hochberg False Discovery Rate (FDR). Gene Symbol NCBILink Annotation Gene Alt. Exon Usage Significant Alt. Exon Usage corrected with Benjamini and Hochberg FalseDiscovery Rate (FDR) hmcn1 NM_031935 hemicentin 1 1.37E-38 1.18E-34 nin NM_020921 ninein (GSK3B interacting protein) 1.22E-38 2.10E-34 sytl2 NM_206928 synaptotagmin-like 2 2.48E-35 1.43E-31 sptlc1 NM_006415 serine palmitoyltransferase long chain base subunit 1 1.37E-31 5.88E-28 antxr1 NM_018153 anthrax toxin receptor 1 1.62E-27 5.59E-24 slc7a5p1 NR_002593 solute carrier family 7 (cationic amino acid transporter y+ system) member 5 pseudogene 1 2.66E-26 7.63E-23 myo6 NM_004999 myosin VI 2.52E-25 6.20E-22 zhx1 NM_007222 zinc fingers and homeoboxes 1 2.41E-23 5.19E-20 kiaa1429 NM_015496 KIAA1429 8.71E-22 1.67E-18 ctnnd1 NM_001331 catenin (cadherin-associated protein) delta 1 2.34E-17 4.03E-14 thrap1 NM_005121 thyroid hormone receptor associated protein 1 2.73E-17 4.28E-14 ncoa4 NM_005437 nuclear receptor coactivator 4 7.87E-17 1.13E-13 dock1 NM_001380 dedicator of cytokinesis 1 1.04E-16 1.38E-13 utrn NM_007124 utrophin 1.21E-16 1.48E-13 mina NM_153182 MYC induced nuclear antigen 4.74E-16 5.44E-13 myef2 NM_016132 myelin expression factor 2 7.29E-16 7.85E-13 fam62b NM_020728 family with sequence similarity 62 (C2 domain containing) member B 4.67E-15 4.74E-12 dst NM_183380 dystonin 9.08E-15 8.69E-12 epb41l1 NM_012156 erythrocyte membrane protein band 4.1-like 1 1.34E-14 1.21E-11 ncoa3 NM_181659 nuclear receptor coactivator 3 1.84E-14 1.59E-11 stag2 NM_001042749 stromal antigen 2 3.78E-14 3.10E-11 pten NM_000314 phosphatase and tensin homolog (mutated in multiple advanced cancers 1) 3.97E-14 3.11E-11 prmt3 NM_005788 protein arginine methyltransferase 3 4.59E-14 3.44E-11 pspc1 NM_001042414 paraspeckle component 1 5.34E-14 3.83E-11 atp2a2 NM_170665 ATPase Ca++ transporting cardiac muscle slow twitch 2 1.09E-13 7.52E-11 ipo7 NM_006391 importin 7 1.31E-13 8.36E-11 camsap1l1 NM_203459 calmodulin regulated spectrin-associated protein 1-like 1 1.31E-13 8.66E-11 ugcg NM_003358 UDP-glucose ceramide glucosyltransferase 2.42E-13 1.49E-10 paics NM_001079524 phosphoribosylaminoimidazole carboxylase phosphoribosylaminoimidazole succinocarboxamide synthetase5.10E-13 3.03E-10 isoc1 NM_016048 isochorismatase domain containing 1 1.11E-12 6.19E-10 gtf2i NM_033000 general transcription factor II i 1.11E-12 6.37E-10 smg1 NM_015092 PI-3-kinase-related kinase SMG-1 1.57E-12 8.46E-10 ube3a NM_130839 ubiquitin protein ligase E3A (human papilloma virus E6-associated protein Angelman syndrome) 1.88E-12 9.83E-10 asph NM_004318 aspartate beta-hydroxylase 2.10E-12 1.06E-09 ttc3 NM_001001894 tetratricopeptide repeat domain 3 2.59E-12 1.27E-09 ptpn13 NM_080685 protein tyrosine phosphatase non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) 4.11E-12 1.91E-09 c1orf21 NM_030806 chromosome 1 open reading frame 21 4.06E-12 1.94E-09 dhx15 NM_001358 DEAH (Asp-Glu-Ala-His) box polypeptide 15 4.88E-12 2.21E-09 atp6v0a4 NM_130841 ATPase H+ transporting lysosomal V0 subunit a4 7.06E-12 3.12E-09 hexb NM_000521 hexosaminidase B (beta polypeptide) 8.60E-12 3.70E-09 osbp NM_002556 oxysterol binding protein 1.51E-11 6.36E-09 ppp1cb NM_002709 protein phosphatase 1 catalytic subunit beta isoform 2.06E-11 8.44E-09 fancd2 NM_033084 Fanconi anemia complementation group D2 2.85E-11 1.14E-08 ak7 NM_152327 adenylate kinase 7 3.04E-11 1.17E-08 setd7 NM_030648 SET domain containing (lysine methyltransferase) 7 3.01E-11 1.18E-08 ldha NM_005566 lactate dehydrogenase A 3.35E-11 1.23E-08 crot NM_021151 carnitine O-octanoyltransferase 3.30E-11 1.24E-08 yme1l1 NM_139313 YME1-like 1 (S. cerevisiae) 3.87E-11 1.39E-08 stau1 NM_001037328 staufen RNA binding protein homolog 1 (Drosophila) 5.24E-11 1.84E-08 kif5b NM_004521 kinesin family member 5B 5.76E-11 1.98E-08 mbnl2 NM_144778 muscleblind-like 2 (Drosophila) 9.12E-11 3.08E-08 bccip NM_016567 BRCA2 and CDKN1A interacting protein 9.78E-11 3.18E-08 acbd5 NM_145698 acyl-Coenzyme A binding domain containing 5 9.72E-11 3.22E-08 ppm1b NM_002706 protein phosphatase 1B (formerly 2C) magnesium-dependent beta isoform 1.35E-10 4.32E-08 dhx40 NM_024612 DEAH (Asp-Glu-Ala-His) box polypeptide 40 1.79E-10 5.61E-08 xrn2 NM_012255 5'-3' exoribonuclease 2 1.83E-10 5.63E-08 rcn1 NM_002901 reticulocalbin 1 EF-hand calcium binding domain 2.04E-10 6.16E-08 bms1 NM_014753 BMS1 homolog ribosome assembly protein (yeast) 2.23E-10 6.63E-08 slc9a3r1 NM_004252 solute carrier family 9 (sodium/hydrogen exchanger) member 3 regulator 1 3.68E-10 1.07E-07 them4 NM_053055 thioesterase superfamily member 4 3.78E-10 1.09E-07 abr NM_021962 active BCR-related gene 3.97E-10 1.12E-07 iqgap1 NM_003870 IQ motif containing GTPase activating protein 1 4.09E-10 1.14E-07 armcx6 NM_019007 armadillo repeat containing X-linked 6 4.39E-10 1.20E-07 rtn4 NM_020532 reticulon 4 5.73E-10 1.54E-07 brwd1 NM_033656 bromodomain and WD repeat domain containing 1 7.83E-10 2.04E-07 hsmpp8 NM_017520 M-phase phosphoprotein mpp8 7.78E-10 2.06E-07 cnot2 NM_014515 CCR4-NOT transcription complex subunit 2 8.74E-10 2.25E-07 pa2g4 NM_006191 proliferation-associated 2G4 38kDa 9.09E-10 2.30E-07 cse1l NM_001316 CSE1 chromosome segregation 1-like (yeast) 1.22E-09 3.05E-07 sulf1 NM_015170 sulfatase 1 1.25E-09 3.07E-07 ncor1 NM_006311 nuclear receptor co-repressor 1 1.31E-09 3.17E-07 mon2 NM_015026 MON2 homolog (S. cerevisiae) 1.50E-09 3.60E-07 ehbp1 NM_015252 EH domain binding protein 1 1.61E-09 3.80E-07 ddx6 NM_004397 DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 1.78E-09 4.14E-07 ran NM_006325 RAN member RAS oncogene family 1.86E-09 4.22E-07 fer1l3 NM_133337 fer-1-like 3 myoferlin (C. elegans) 1.89E-09 4.22E-07 ywhae NM_006761 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon polypeptide 1.85E-09 4.25E-07 enosf1 NM_017512 enolase superfamily member 1 2.85E-09 6.30E-07 thoc2 NM_020449 THO complex 2 3.01E-09 6.56E-07 ppp3r1 NM_000945 protein phosphatase 3 (formerly 2B) regulatory subunit B alpha isoform 3.43E-09 7.38E-07 npnt NM_001033047 nephronectin 4.17E-09 8.76E-07 flj20273 AF262323 RNA-binding protein 4.12E-09 8.76E-07 prdm4 NM_012406 PR domain containing 4 4.60E-09 9.54E-07 baz1a NM_013448 bromodomain adjacent to zinc finger domain 1A 4.81E-09 9.87E-07 polr3k NM_016310 polymerase (RNA) III (DNA directed) polypeptide K 12.3 kDa 5.82E-09 1.18E-06 sec14l1 NM_003003 SEC14-like 1 (S. cerevisiae) 8.13E-09 1.63E-06 hipk1 NM_198269 homeodomain interacting protein kinase 1 8.73E-09 1.73E-06 uros NM_000375 uroporphyrinogen III synthase (congenital erythropoietic porphyria) 8.96E-09 1.75E-06 esr1 NM_000125 estrogen receptor 1 1.20E-08 2.33E-06 helz NM_014877 helicase with zinc finger 1.27E-08 2.43E-06 dstn NM_001011546 destrin (actin depolymerizing factor) 1.52E-08 2.87E-06 vezt NM_017599 vezatin adherens junctions transmembrane protein 1.71E-08 3.21E-06 kiaa0265 NM_014997 KIAA0265 protein 1.82E-08 3.36E-06 acp1 NM_004300 acid phosphatase 1 soluble 2.77E-08 5.07E-06 cnot1 NM_016284 CCR4-NOT transcription complex subunit 1 3.18E-08 5.76E-06 ppp1r10 NM_002714 protein phosphatase 1 regulatory (inhibitor) subunit 10 3.60E-08 6.45E-06 rps6kb1 NM_003161 ribosomal protein S6 kinase 70kDa polypeptide 1 3.95E-08 6.94E-06 atad2 NM_014109 ATPase family AAA domain containing 2 3.93E-08 6.97E-06 zmynd11 NM_212479 zinc finger MYND domain containing 11 4.52E-08 7.87E-06 prex1 NM_020820 phosphatidylinositol 3 4 5-trisphosphate-dependent RAC exchanger 1 4.90E-08 8.44E-06 rad51c NM_058216 RAD51 homolog C (S. cerevisiae) 5.01E-08 8.55E-06 epb41l2 NM_001431 erythrocyte membrane protein band 4.1-like 2 5.20E-08 8.78E-06 ybx1 NM_004559 Y box binding protein 1 5.43E-08 9.00E-06 pex1 NM_000466 peroxisome biogenesis factor 1 5.42E-08 9.07E-06 tegt NM_003217 testis enhanced gene transcript (BAX inhibitor 1) 5.56E-08 9.12E-06 znf217 NM_006526 zinc finger protein 217 6.09E-08 9.89E-06 idh1 NM_005896 isocitrate dehydrogenase 1 (NADP+) soluble 6.15E-08 9.90E-06 nomo1 NM_014287 NODAL modulator 1 6.31E-08 1.01E-05 bptf NM_004459 bromodomain PHD finger transcription factor 6.44E-08 1.01E-05 mthfd1l NM_015440 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like 6.42E-08 1.01E-05 osbpl1a NM_133268 oxysterol binding protein-like 1A 6.80E-08 1.06E-05 appbp1 NM_001018159 amyloid beta precursor protein binding protein 1 7.09E-08 1.09E-05 pggt1b NM_005023 protein geranylgeranyltransferase type I beta subunit 7.52E-08 1.15E-05 psmd12 NM_002816 proteasome (prosome macropain) 26S subunit non-ATPase 12 7.73E-08 1.17E-05 azin1 NM_148174 antizyme inhibitor 1 8.40E-08 1.25E-05 fus NM_001010850 fusion (involved in t(12;16) in malignant liposarcoma) 8.33E-08 1.25E-05 xbp1 NM_001079539 X-box binding protein 1 1.00E-07 1.47E-05 calm1 NM_006888 calmodulin 1 (phosphorylase kinase delta) 1.09E-07 1.58E-05 tia1 NM_022173 TIA1 cytotoxic granule-associated RNA binding protein 1.09E-07 1.59E-05 sdccag1 NM_004713 serologically defined colon cancer antigen 1 1.11E-07 1.59E-05 mrlc2 NM_033546 myosin regulatory light chain MRLC2 1.13E-07 1.60E-05 dicer1 NM_177438 Dicer1 Dcr-1 homolog (Drosophila) 1.17E-07 1.65E-05 trim37 NM_001005207 tripartite motif-containing 37 1.19E-07 1.67E-05 rp11-217h1.1 NM_032121 implantation-associated protein 1.21E-07 1.68E-05 edd1 NM_015902 E3 ubiquitin protein ligase HECT domain containing 1 1.26E-07 1.73E-05 garnl1 NM_014990 GTPase activating Rap/RanGAP domain-like 1 1.29E-07 1.76E-05 purb NM_033224 purine-rich element binding protein B 1.34E-07 1.82E-05 prkar1a NM_212472 protein kinase cAMP-dependent regulatory type I alpha (tissue specific extinguisher 1) 1.35E-07 1.82E-05 usp10 NM_005153 ubiquitin specific peptidase 10 1.42E-07 1.88E-05 sulf2 NM_198596 sulfatase 2 1.41E-07 1.88E-05 ckap5 NM_001008938 cytoskeleton associated protein 5 1.49E-07 1.96E-05 unc13b NM_006377 unc-13 homolog B (C.
Load more

Recommended publications
  • Supplementary Data
    Figure 2S 4 7 A - C 080125 CSCs 080418 CSCs - + IFN-a 48 h + IFN-a 48 h + IFN-a 72 h 6 + IFN-a 72 h 3 5 MRFI 4 2 3 2 1 1 0 0 MHC I MHC II MICA MICB ULBP-1 ULBP-2 ULBP-3 ULBP-4 MHC I MHC II MICA MICB ULBP-1 ULBP-2 ULBP-3 ULBP-4 7 B 13 080125 FBS - D 080418 FBS - + IFN-a 48 h 12 + IFN-a 48 h + IFN-a 72 h + IFN-a 72 h 6 080125 FBS 11 10 5 9 8 4 7 6 3 MRFI 5 4 2 3 2 1 1 0 0 MHC I MHC II MICA MICB ULBP-1 ULBP-2 ULBP-3 ULBP-4 MHC I MHC II MICA MICB ULBP-1 ULBP-2 ULBP-3 ULBP-4 Molecule Molecule FIGURE 4S FIGURE 5S Panel A Panel B FIGURE 6S A B C D Supplemental Results Table 1S. Modulation by IFN-α of APM in GBM CSC and FBS tumor cell lines. Molecule * Cell line IFN-α‡ HLA β2-m# HLA LMP TAP1 TAP2 class II A A HC§ 2 7 10 080125 CSCs - 1∞ (1) 3 (65) 2 (91) 1 (2) 6 (47) 2 (61) 1 (3) 1 (2) 1 (3) + 2 (81) 11 (80) 13 (99) 1 (3) 8 (88) 4 (91) 1 (2) 1 (3) 2 (68) 080125 FBS - 2 (81) 4 (63) 4 (83) 1 (3) 6 (80) 3 (67) 2 (86) 1 (3) 2 (75) + 2 (99) 14 (90) 7 (97) 5 (75) 7 (100) 6 (98) 2 (90) 1 (4) 3 (87) 080418 CSCs - 2 (51) 1 (1) 1 (3) 2 (47) 2 (83) 2 (54) 1 (4) 1 (2) 1 (3) + 2 (81) 3 (76) 5 (75) 2 (50) 2 (83) 3 (71) 1 (3) 2 (87) 1 (2) 080418 FBS - 1 (3) 3 (70) 2 (88) 1 (4) 3 (87) 2 (76) 1 (3) 1 (3) 1 (2) + 2 (78) 7 (98) 5 (99) 2 (94) 5 (100) 3 (100) 1 (4) 2 (100) 1 (2) 070104 CSCs - 1 (2) 1 (3) 1 (3) 2 (78) 1 (3) 1 (2) 1 (3) 1 (3) 1 (2) + 2 (98) 8 (100) 10 (88) 4 (89) 3 (98) 3 (94) 1 (4) 2 (86) 2 (79) * expression of APM molecules was evaluated by intracellular staining and cytofluorimetric analysis; ‡ cells were treatead or not (+/-) for 72 h with 1000 IU/ml of IFN-α; # β-2 microglobulin; § β-2 microglobulin-free HLA-A heavy chain; ∞ values are indicated as ratio between the mean of fluorescence intensity of cells stained with the selected mAb and that of the negative control; bold values indicate significant MRFI (≥ 2).
    [Show full text]
  • An Order Estimation Based Approach to Identify Response Genes
    AN ORDER ESTIMATION BASED APPROACH TO IDENTIFY RESPONSE GENES FOR MICRO ARRAY TIME COURSE DATA A Thesis Presented to The Faculty of Graduate Studies of The University of Guelph by ZHIHENG LU In partial fulfilment of requirements for the degree of Doctor of Philosophy September, 2008 © Zhiheng Lu, 2008 Library and Bibliotheque et 1*1 Archives Canada Archives Canada Published Heritage Direction du Branch Patrimoine de I'edition 395 Wellington Street 395, rue Wellington Ottawa ON K1A0N4 Ottawa ON K1A0N4 Canada Canada Your file Votre reference ISBN: 978-0-494-47605-5 Our file Notre reference ISBN: 978-0-494-47605-5 NOTICE: AVIS: The author has granted a non­ L'auteur a accorde une licence non exclusive exclusive license allowing Library permettant a la Bibliotheque et Archives and Archives Canada to reproduce, Canada de reproduire, publier, archiver, publish, archive, preserve, conserve, sauvegarder, conserver, transmettre au public communicate to the public by par telecommunication ou par Plntemet, prefer, telecommunication or on the Internet, distribuer et vendre des theses partout dans loan, distribute and sell theses le monde, a des fins commerciales ou autres, worldwide, for commercial or non­ sur support microforme, papier, electronique commercial purposes, in microform, et/ou autres formats. paper, electronic and/or any other formats. The author retains copyright L'auteur conserve la propriete du droit d'auteur ownership and moral rights in et des droits moraux qui protege cette these. this thesis. Neither the thesis Ni la these ni des extraits substantiels de nor substantial extracts from it celle-ci ne doivent etre imprimes ou autrement may be printed or otherwise reproduits sans son autorisation.
    [Show full text]
  • Enzymatic Encoding Methods for Efficient Synthesis Of
    (19) TZZ__T (11) EP 1 957 644 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C12N 15/10 (2006.01) C12Q 1/68 (2006.01) 01.12.2010 Bulletin 2010/48 C40B 40/06 (2006.01) C40B 50/06 (2006.01) (21) Application number: 06818144.5 (86) International application number: PCT/DK2006/000685 (22) Date of filing: 01.12.2006 (87) International publication number: WO 2007/062664 (07.06.2007 Gazette 2007/23) (54) ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES ENZYMVERMITTELNDE KODIERUNGSMETHODEN FÜR EINE EFFIZIENTE SYNTHESE VON GROSSEN BIBLIOTHEKEN PROCEDES DE CODAGE ENZYMATIQUE DESTINES A LA SYNTHESE EFFICACE DE BIBLIOTHEQUES IMPORTANTES (84) Designated Contracting States: • GOLDBECH, Anne AT BE BG CH CY CZ DE DK EE ES FI FR GB GR DK-2200 Copenhagen N (DK) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • DE LEON, Daen SK TR DK-2300 Copenhagen S (DK) Designated Extension States: • KALDOR, Ditte Kievsmose AL BA HR MK RS DK-2880 Bagsvaerd (DK) • SLØK, Frank Abilgaard (30) Priority: 01.12.2005 DK 200501704 DK-3450 Allerød (DK) 02.12.2005 US 741490 P • HUSEMOEN, Birgitte Nystrup DK-2500 Valby (DK) (43) Date of publication of application: • DOLBERG, Johannes 20.08.2008 Bulletin 2008/34 DK-1674 Copenhagen V (DK) • JENSEN, Kim Birkebæk (73) Proprietor: Nuevolution A/S DK-2610 Rødovre (DK) 2100 Copenhagen 0 (DK) • PETERSEN, Lene DK-2100 Copenhagen Ø (DK) (72) Inventors: • NØRREGAARD-MADSEN, Mads • FRANCH, Thomas DK-3460 Birkerød (DK) DK-3070 Snekkersten (DK) • GODSKESEN,
    [Show full text]
  • Broad Poster Vivek
    A novel computational method for finding regions with copy number abnormalities in cancer cells Vivek, Manuel Garber, and Mike Zody Broad Institute of MIT and Harvard, Cambridge, MA, USA Introduction Results Cancer can result from the over expression of oncogenes, genes which control and regulate cell growth. Sometimes oncogenes increase in 1 2 3 activity due to a specific genetic mutation called a translocation (Fig 1). SMAD4 – a gene known to be deleted in pancreatic COX10 – a gene deleted in cytochrome c oxidase AK001392 – a hereditary prostate cancer protein This translocation allows the oncogene to remain as active as its paired carcinoma deficiency, known to be related to cell proliferation gene. Amplification of this mutation can occur, thereby creating the proper conditions for uncontrolled cell growth; consequently, each Results from Analysis Program Results from Analysis Program Results from Analysis Program component of the translocation will amplify in similar quantities. In this mutation, the chromosomal region containing the oncogene displaces to Region 1 Region 2 R2 Region 1 Region 2 R2 Region 1 Region 2 R2 a region on another chromosome containing a gene that is expressed Chr18:47044749-47311978 Chr17:13930739-14654741 0.499070821478475 Chr17:13930739-14654741 Chr18:26861790-27072166 0.47355172850856 Chr17:12542326-13930738 Chr8:1789292-1801984 0.406208680312004 frequently. Actual region containing gene Actual region containing gene Actual region containing gene chr18: 45,842,214 - 48,514,513 chr17: 13,966,862 - 14,068,461 chr17: 12,542,326 - 13,930,738 Fig 1. Two chromosomal regions (abcdef and ghijk) are translocating to create two new regions (abckl and ghijedf).
    [Show full text]
  • The Purification and Identification of Interactors to Elucidate Novel Connections in the HEK 293 Cell Line
    The Purification and Identification of Interactors to Elucidate Novel Connections in the HEK 293 Cell Line Brett Hawley Biochemistry, Microbiology and Immunology Faculty of Medicine University of Ottawa © Brett Hawley, Ottawa, Canada, 2012 ABSTRACT The field of proteomics studies the structure and function of proteins in a large scale and high throughput manner. My work in the field of proteomics focuses on identifying interactions between proteins and discovering novel interactions. The identification of these interactions provides new information on metabolic and disease pathways and the working proteome of a cell. Cells are lysed and purified using antibody based affinity purification followed by digestion and identification using an HPLC coupled to a mass spectrometer. In my studies, I looked at the interaction networks of several AD related genes (Apolipoprotein E, Clusterin variant 1 and 2, Low-density lipoprotein receptor, Phosphatidylinositol binding clathrin assembly protein, Alpha- synuclein and Platelet-activating factor receptor) and an endosomal recycling pathway involved in cholesterol metabolism (Eps15 homology domain 1,2 and 4, Proprotein convertase subtilisin/kexin type 9 and Low-density lipoprotein receptor). Several novel and existing interactors were identified and these interactions were validated using co-immunopurification, which could be the basis for future research. ii ACKNOWLEDGEMENTS I would like to take this opportunity to thank my supervisor, Dr. Daniel Figeys, for his support and guidance throughout my studies in his lab. It was a great experience to work in his lab and I am very thankful I was given the chance to learn and work under him. I would also like to thank the members of my lab for all their assistance in learning new techniques and equipment in the lab.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Microrna Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms Behind Variable Drug Disposition and Strategy to Develop More Effective Therapy
    1521-009X/44/3/308–319$25.00 http://dx.doi.org/10.1124/dmd.115.067470 DRUG METABOLISM AND DISPOSITION Drug Metab Dispos 44:308–319, March 2016 Copyright ª 2016 by The American Society for Pharmacology and Experimental Therapeutics Minireview MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy Ai-Ming Yu, Ye Tian, Mei-Juan Tu, Pui Yan Ho, and Joseph L. Jilek Department of Biochemistry & Molecular Medicine, University of California Davis School of Medicine, Sacramento, California Received September 30, 2015; accepted November 12, 2015 Downloaded from ABSTRACT Knowledge of drug absorption, distribution, metabolism, and excre- we review the advances in miRNA pharmacoepigenetics including tion (ADME) or pharmacokinetics properties is essential for drug the mechanistic actions of miRNAs in the modulation of Phase I and development and safe use of medicine. Varied or altered ADME may II drug-metabolizing enzymes, efflux and uptake transporters, and lead to a loss of efficacy or adverse drug effects. Understanding the xenobiotic receptors or transcription factors after briefly introducing causes of variations in drug disposition and response has proven the characteristics of miRNA-mediated posttranscriptional gene dmd.aspetjournals.org critical for the practice of personalized or precision medicine. The regulation. Consequently, miRNAs may have significant influence rise of noncoding microRNA (miRNA) pharmacoepigenetics and on drug disposition and response. Therefore, research on miRNA pharmacoepigenomics has come with accumulating evidence sup- pharmacoepigenetics shall not only improve mechanistic under- porting the role of miRNAs in the modulation of ADME gene standing of variations in pharmacotherapy but also provide novel expression and then drug disposition and response.
    [Show full text]
  • Genes in a Refined Smith-Magenis Syndrome Critical Deletion Interval on Chromosome 17P11.2 and the Syntenic Region of the Mouse
    Downloaded from genome.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press Article Genes in a Refined Smith-Magenis Syndrome Critical Deletion Interval on Chromosome 17p11.2 and the Syntenic Region of the Mouse Weimin Bi,1,6 Jiong Yan,1,6 Paweł Stankiewicz,1 Sung-Sup Park,1,7 Katherina Walz,1 Cornelius F. Boerkoel,1 Lorraine Potocki,1,3 Lisa G. Shaffer,1 Koen Devriendt,4 Małgorzata J.M. Nowaczyk,5 Ken Inoue,1 and James R. Lupski1,2,3,8 Departments of 1Molecular & Human Genetics, 2Pediatrics, Baylor College of Medicine, 3Texas Children’s Hospital, Houston, Texas 77030, USA; 4Centre for Human Genetics, University Hospital Gasthuisberg, Catholic University of Leuven, B-3000 Leuven, Belgium; 5Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario L8S 4J9, Canada Smith-Magenis syndrome (SMS) is a multiple congenital anomaly/mental retardation syndrome associated with behavioral abnormalities and sleep disturbance. Most patients have the same ∼4 Mb interstitial genomic deletion within chromosome 17p11.2. To investigate the molecular bases of the SMS phenotype, we constructed BAC/PAC contigs covering the SMS common deletion interval and its syntenic region on mouse chromosome 11. Comparative genome analysis reveals the absence of all three ∼200-kb SMS-REP low-copy repeats in the mouse and indicates that the evolution of SMS-REPs was accompanied by transposition of adjacent genes. Physical and genetic map comparisons in humans reveal reduced recombination in both sexes. Moreover, by examining the deleted regions in SMS patients with unusual-sized deletions, we refined the minimal Smith-Magenis critical region (SMCR) to an ∼1.1-Mb genomic interval that is syntenic to an ∼1.0-Mb region in the mouse.
    [Show full text]
  • Calmodulin and Calmodulin-Dependent Protein Kinase II Inhibit Hormone Secretion in Human Parathyroid Adenoma
    31 Calmodulin and calmodulin-dependent protein kinase II inhibit hormone secretion in human parathyroid adenoma Ming Lu1,2,3, Erik Berglund1, Catharina Larsson1,3, Anders Ho¨o¨g4, Lars-Ove Farnebo1 and Robert Bra¨nstro¨m1 1Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital L1:03, SE-171 76 Stockholm, Sweden 2Department of Geriatric Endocrinology, First Affiliated Hospital of Guangxi Medical University, NanNing, People’s Republic of China 3Center for Molecular Medicine (CMM), Karolinska University Hospital, SE-171 76 Stockholm, Sweden 4Department of Oncology–Pathology, Karolinska Institutet, Karolinska University Hospital, SE-171 76 Stockholm, Sweden (Correspondence should be addressed to M Lu at Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital; Email: [email protected]) Abstract 2C 2C Intracellular calcium ([Ca ]i) is the most relevant modulator adenoma cells in spite of increased [Ca ]i. The inhibitory C of parathyroid hormone (PTH) secretion. Uniquely, an effect of Ca2 calmodulin on PTH secretion may be due to 2C increase in [Ca ]i results in an inhibition of PTH secretion, the absence of synaptotagmin 1 protein in parathyroid and it probably exerts its function via calcium-binding protein adenomas, as demonstrated by western blot analysis. An pathways. The ubiquitous calcium-binding proteins, calmo- increased extracellular calcium level acutely lowered the dulin and calmodulin-dependent protein kinase II (CaMKII), amount of active phosphorylated CaMKII (pCaMKII) in have well-established roles in regulated exocytosis in neurons adenoma cells in vitro, indicating the physiological importance and neuroendocrine cells. However, their roles in parathyroid of this pathway. Moreover, a negative correlation between the cells and PTH secretion are still unclear.
    [Show full text]
  • Dependent Traits in Mice Models of Hyperthyroidism and Hypothyroidism
    Phenotypical characterization of sex- dependent traits in mice models of hyperthyroidism and hypothyroidism Inaugural-Dissertation zur Erlangung des Doktorgrades Dr. rer. nat. der Fakultät für Biologie an der Universität Duisburg-Essen vorgelegt von Helena Rakov aus St. Petropawlowsk April 2017 Die der vorliegenden Arbeit zugrunde liegenden Experimente wurden am Universitätsklinikum Essen in der Klinik für Endokrinologie und Stoffwechselerkrankungen durchgeführt. 1. Gutachter: Prof. Dr. Dr. Dagmar Führer-Sakel 2. Gutachter: Prof. Dr. Elke Cario Vorsitzender des Prüfungsausschusses: Prof. Dr. Ruth Grümmer Tag der mündlichen Prüfung: 17.07.2017 Publications Publications Engels Kathrin*, Rakov Helena *, Zwanziger Denise, Moeller Lars C., Homuth Georg, Köhrle Josef, Brix Klaudia, Fuhrer Dagmar. Differences in mouse hepatic thyroid hormone transporter expression with age and hyperthyroidism. Eur Thyroid J 2015;4(suppl 1):81–86. DOI: 10.1159/000381020. *contributed equally Zwanziger Denise*, Rakov Helena*, Engels Kathrin, Moeller Lars C., Fuhrer Dagmar. Sex-dependent claudin-1 expression in liver of eu- and hypothyroid mice. Eur Thyroid J. 2015 Sep; 4(Suppl 1): 67–73. DOI: 10.1159/000431316. *contributed equally Engels Kathrin*, Rakov Helena*, Zwanziger Denise, Hoenes Georg Sebastian, Rehders Maren, Brix Klaudia, Koehrle Josef, Moeller Lars Christian, Fuhrer Dagmar. Efficacy of protocols for induction of chronic hyperthyroidism in male and female mice. Endocrine. 2016 Oct;54(1):47-54. DOI: 10.1007/s12020-016-1020-8. Rakov Helena*, Engels Kathrin*, Hönes Georg Sebastian, Strucksberg Karl-Heinz, Moeller Lars Christian, Köhrle Josef, Zwanziger Denise, Führer Dagmar. Sex-specific phenotypes of hyperthyroidism and hypothyroidism in mice. Biol Sex Differ. 2016 Aug 24;7(1):36. DOI: 10.1186/s13293-016-0089-3.
    [Show full text]
  • 1 Supporting Information for a Microrna Network Regulates
    Supporting Information for A microRNA Network Regulates Expression and Biosynthesis of CFTR and CFTR-ΔF508 Shyam Ramachandrana,b, Philip H. Karpc, Peng Jiangc, Lynda S. Ostedgaardc, Amy E. Walza, John T. Fishere, Shaf Keshavjeeh, Kim A. Lennoxi, Ashley M. Jacobii, Scott D. Rosei, Mark A. Behlkei, Michael J. Welshb,c,d,g, Yi Xingb,c,f, Paul B. McCray Jr.a,b,c Author Affiliations: Department of Pediatricsa, Interdisciplinary Program in Geneticsb, Departments of Internal Medicinec, Molecular Physiology and Biophysicsd, Anatomy and Cell Biologye, Biomedical Engineeringf, Howard Hughes Medical Instituteg, Carver College of Medicine, University of Iowa, Iowa City, IA-52242 Division of Thoracic Surgeryh, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada-M5G 2C4 Integrated DNA Technologiesi, Coralville, IA-52241 To whom correspondence should be addressed: Email: [email protected] (M.J.W.); yi- [email protected] (Y.X.); Email: [email protected] (P.B.M.) This PDF file includes: Materials and Methods References Fig. S1. miR-138 regulates SIN3A in a dose-dependent and site-specific manner. Fig. S2. miR-138 regulates endogenous SIN3A protein expression. Fig. S3. miR-138 regulates endogenous CFTR protein expression in Calu-3 cells. Fig. S4. miR-138 regulates endogenous CFTR protein expression in primary human airway epithelia. Fig. S5. miR-138 regulates CFTR expression in HeLa cells. Fig. S6. miR-138 regulates CFTR expression in HEK293T cells. Fig. S7. HeLa cells exhibit CFTR channel activity. Fig. S8. miR-138 improves CFTR processing. Fig. S9. miR-138 improves CFTR-ΔF508 processing. Fig. S10. SIN3A inhibition yields partial rescue of Cl- transport in CF epithelia.
    [Show full text]
  • Bioinformatic Analyses in Early Host Response To
    Schroyen et al. BMC Genomics (2016) 17:196 DOI 10.1186/s12864-016-2547-z RESEARCH ARTICLE Open Access Bioinformatic analyses in early host response to Porcine Reproductive and Respiratory Syndrome virus (PRRSV) reveals pathway differences between pigs with alternate genotypes for a major host response QTL Martine Schroyen1†, Christopher Eisley2†, James E. Koltes3, Eric Fritz-Waters1, Igseo Choi4, Graham S. Plastow5, Leluo Guan5, Paul Stothard5, Hua Bao5, Arun Kommadath5, James M. Reecy1, Joan K. Lunney4, Robert R. R. Rowland6, Jack C. M. Dekkers1 and Christopher K. Tuggle1* Abstract Background: AregiononSus scrofa chromosome 4 (SSC4) surrounding single nucleotide polymorphism (SNP) marker WUR10000125 (WUR) has been reported to be strongly associated with both weight gain and serum viremia in pigs after infection with PRRS virus (PRRSV). A proposed causal mutation in the guanylate binding protein 5 gene (GBP5)is predicted to truncate the encoded protein. To investigate transcriptional differences between WUR genotypes in early host response to PRRSV infection, an RNA-seq experiment was performed on globin depleted whole blood RNA collectedon0,4,7,10and14dayspost-infection(dpi)from eight littermate pairs with one AB (favorable) and one AA (unfavorable) WUR genotype animal per litter. Results: Gene Ontology (GO) enrichment analysis of transcripts that were differentially expressed (DE) between dpi across both genotypes revealed an inflammatory response for all dpi when compared to day 0. However, at the early time points of 4 and 7dpi, several GO terms had higher enrichment scores compared to later dpi, including inflammatory response (p <10-7), specifically regulation of NFkappaB (p < 0.01), cytokine, and chemokine activity (p <0.01).At10and 14dpi, GO term enrichment indicated a switch to DNA damage response, cell cycle checkpoints, and DNA replication.
    [Show full text]